These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30257490)

  • 21. Challenges and advances in genetic manipulation of filamentous actinomycetes - the remarkable producers of specialized metabolites.
    Musiol-Kroll EM; Tocchetti A; Sosio M; Stegmann E
    Nat Prod Rep; 2019 Sep; 36(9):1351-1369. PubMed ID: 31517370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-Scale Metabolic Reconstruction of Actinomycetes for Antibiotics Production.
    Mohite OS; Weber T; Kim HU; Lee SY
    Biotechnol J; 2019 Jan; 14(1):e1800377. PubMed ID: 30117679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of novel secondary metabolites encoded in actinomycete genomes through coculture.
    Kim JH; Lee N; Hwang S; Kim W; Lee Y; Cho S; Palsson BO; Cho BK
    J Ind Microbiol Biotechnol; 2021 Jun; 48(3-4):. PubMed ID: 33825906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycopeptide antibiotic discovery in the genomic era.
    Xu M; Wang W; Wright GD
    Methods Enzymol; 2022; 665():325-346. PubMed ID: 35379441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes.
    Weber T; Charusanti P; Musiol-Kroll EM; Jiang X; Tong Y; Kim HU; Lee SY
    Trends Biotechnol; 2015 Jan; 33(1):15-26. PubMed ID: 25497361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural product drug discovery in the genomic era: realities, conjectures, misconceptions, and opportunities.
    Baltz RH
    J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):281-299. PubMed ID: 30484124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diversity and taxonomic distribution of bacterial biosynthetic gene clusters predicted to produce compounds with therapeutically relevant bioactivities.
    Beck ML; Song S; Shuster IE; Miharia A; Walker AS
    J Ind Microbiol Biotechnol; 2023 Feb; 50(1):. PubMed ID: 37653463
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    De Simeis D; Serra S
    Antibiotics (Basel); 2021 Apr; 10(5):. PubMed ID: 33922100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of Secondary Metabolism of Hypogean Actinobacterial Genera to Chemical and Biological Stimuli.
    Covington BC; Spraggins JM; Ynigez-Gutierrez AE; Hylton ZB; Bachmann BO
    Appl Environ Microbiol; 2018 Oct; 84(19):. PubMed ID: 30030223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development and application of ribosomal engineering in actinomycetes].
    Xie Y; Yao S; Li W; Shan R; Wu G; Tong T; Chen Q
    Sheng Wu Gong Cheng Xue Bao; 2022 Feb; 38(2):546-564. PubMed ID: 35234381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Old and new glycopeptide antibiotics: From product to gene and back in the post-genomic era.
    Marcone GL; Binda E; Berini F; Marinelli F
    Biotechnol Adv; 2018; 36(2):534-554. PubMed ID: 29454983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Returning to Nature for the Next Generation of Antimicrobial Therapeutics.
    MacNair CR; Tsai CN; Rutherford ST; Tan MW
    Antibiotics (Basel); 2023 Aug; 12(8):. PubMed ID: 37627687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biodiscovery from rare actinomycetes: an eco-taxonomical perspective.
    Kurtböke DI
    Appl Microbiol Biotechnol; 2012 Mar; 93(5):1843-52. PubMed ID: 22297430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic and Chemical Decryption of the Bacteroidetes Phylum for Its Potential to Biosynthesize Natural Products.
    Brinkmann S; Kurz M; Patras MA; Hartwig C; Marner M; Leis B; Billion A; Kleiner Y; Bauer A; Toti L; Pöverlein C; Hammann PE; Vilcinskas A; Glaeser J; Spohn M; Schäberle TF
    Microbiol Spectr; 2022 Jun; 10(3):e0247921. PubMed ID: 35442080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Metabologenomics Analysis of Polar Actinomycetes.
    Soldatou S; Eldjárn GH; Ramsay A; van der Hooft JJJ; Hughes AH; Rogers S; Duncan KR
    Mar Drugs; 2021 Feb; 19(2):. PubMed ID: 33578887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mining for Microbial Gems: Integrating Proteomics in the Postgenomic Natural Product Discovery Pipeline.
    Du C; van Wezel GP
    Proteomics; 2018 Sep; 18(18):e1700332. PubMed ID: 29708658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Actinomycetes as Producers of Biologically Active Terpenoids: Current Trends and Patents.
    Tarasova EV; Luchnikova NA; Grishko VV; Ivshina IB
    Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omics and multi-omics approaches to study the biosynthesis of secondary metabolites in microorganisms.
    Palazzotto E; Weber T
    Curr Opin Microbiol; 2018 Oct; 45():109-116. PubMed ID: 29656009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of phosphonic acid natural products by mining the genomes of 10,000 actinomycetes.
    Ju KS; Gao J; Doroghazi JR; Wang KK; Thibodeaux CJ; Li S; Metzger E; Fudala J; Su J; Zhang JK; Lee J; Cioni JP; Evans BS; Hirota R; Labeda DP; van der Donk WA; Metcalf WW
    Proc Natl Acad Sci U S A; 2015 Sep; 112(39):12175-80. PubMed ID: 26324907
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.